TopFunds

Steris

NYSE: STE

Stock price

210.76 USD

(+0%) TODAY

Health Care EquipmentMedical - Devices
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
1.6
1.3
3.4
3.6
4.8
4.6
2.5
1.1
3.8
6.2
7.9
17.7%
02Free cash flow per share
1.8
2.9
3.4
4.1
4.4
5.2
4
3.9
6.2
7.9
9.9
18.5%
03Dividends per share
1
1.1
1.2
1.3
1.5
1.6
1.7
1.8
2
2.2
2.5
9.6%
04Dividends payout, %
58.9%
84.8%
35.4%
37%
30.2%
33.7%
66.9%
1.7%
53%
35.8%
30.8%
(6.3)%
PROFIT AND LOSS STATEMENT
05Revenue
2,239
2,613
2,620
2,782
3,031
3,108
4,223
4,536
5,139
5,460
5,936
10.2%
06% Change
-
-
-
-
-
-
-
-
-
-
-
10.2%
07Cost of revenue
(1,343)
(1,587)
(1,527)
(1,607)
(1,711)
(1,764)
(2,340)
(2,556)
(2,921)
(3,057)
(3,309)
9.4%
08Gross profit
895.5
1,026
1,093
1,175
1,320
1,343
1,883
1,981
2,218
2,403
2,627
11.4%
09% Margin
40%
39.3%
41.7%
42.2%
43.6%
43.2%
44.6%
43.7%
43.2%
44%
44.3%
42.7% A
10Operating expenses
(682.6)
(800)
(692.9)
(764)
(782.9)
(794.7)
(1,405)
(1,190)
(1,382)
(1,536)
(1,525)
8.4%
11% of Revenue
(30.5)%
(30.6)%
(26.5)%
(27.5)%
(25.8)%
(25.6)%
(33.3)%
(26.2)%
(26.9)%
(28.1)%
(25.7)%
(27.9)% A
12Operating Income
212.9
226.2
399.9
411
537
548.4
477.8
791.1
836.1
866.6
1,102
17.9%
13Income tax expense
(60.3)
(74)
(63.4)
(64.3)
(90.9)
(120.7)
(82.3)
(124.1)
(149.5)
(184.6)
(262.2)
15.8%
14Net Income
110.8
110
290.9
304.1
407.7
397.4
243.9
107
378.2
614.6
785.1
21.6%
15% Margin
5%
4.2%
11.1%
10.9%
13.5%
12.8%
5.8%
2.4%
7.4%
11.3%
13.2%
8.9% A
16Shares Outstanding
71.2
86.1
85.7
85.5
85.6
85.9
98.3
100.2
99.4
99.1
98.7
3.3%
17EPS Basic
1.6
1.3
3.4
3.6
4.8
4.7
2.5
1.1
3.8
6.2
7.9
17.6%
18EPS Diluted
1.6
1.3
3.4
3.6
4.8
4.6
2.5
1.1
3.8
6.2
7.9
17.7%
19EBITDA
358.3
417.3
583.9
640
736.3
774
1,009
1,235
1,412
1,359
1,595
16.1%
% Margin
16%
16%
22.3%
23%
24.3%
24.9%
23.9%
27.2%
27.5%
24.9%
26.9%
23.4% A
20Net Interest Income (expense)
(41)
(41.6)
(44.9)
(42)
(38.3)
(30.8)
(83.2)
(110.8)
(133.3)
(77.9)
(50.9)
2.2%
21Net Debt / EBITDA
3.7
2.9
1.9
1.5
1.3
2
2.9
2.5
2.2
1.5
1
2.1 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
248.8
282.9
201.5
220.6
319.6
220.5
348.3
208.4
207
171.7
439.6
5.9%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
471.5
483.5
528.1
564.8
586.5
609.4
799
865
1,008
1,044
1,093
8.8%
25Other current assets
59.4
53.6
54.3
60
54.4
66.8
156.6
333.7
979.3
203.8
230.4
14.5%
26Inventory
192.8
197.8
205.7
208.2
263.5
315.1
575
604.4
674.5
581.3
631.8
12.6%
27Total Current Assets
972.5
1,018
989.7
1,054
1,224
1,212
1,879
2,011
2,869
2,001
2,395
9.4%
Non-Current Assets
28Net property, plant & equipment
1,064
915.9
1,011
1,032
1,244
1,386
1,741
1,799
1,938
2,113
2,316
8.1%
29Long-term investments
-
-
-
-
-
8.6
8.1
-
-
14.3
-
13.7%
30Other non-current assets
3,310
2,991
3,200
2,988
2,973
3,969
7,795
7,011
6,256
6,019
6,026
6.2%
31Total Non-Current Assets
4,374
3,907
4,211
4,019
4,217
5,363
9,545
8,810
8,195
8,146
8,343
6.7%
Total Assets
5,346
4,925
5,200
5,073
5,441
6,575
11,424
10,822
11,064
10,147
10,737
7.2%
LIABILITIES
Current Liabilities
32Accounts payable
139.6
133.5
135.9
152.9
149.3
157
225.7
264.2
251.7
280.8
338.8
9.3%
33Short-term debt
-
-
-
-
19.8
22.8
179.3
90.1
117.2
159.2
154.7
40.9%
34Other current liabilities
261
248.1
262.6
312.3
334.5
398.2
517.1
507.6
562.2
582.2
651.5
9.6%
35Total Current Liabilities
400.6
381.6
398.5
465.2
503.6
577.9
922.2
861.8
931.1
1,022
1,145
11.1%
Non-Current Liabilities
36Long-term debt
1,568
1,478
1,316
1,183
1,265
1,780
3,101
3,158
3,266
2,043
1,932
2.1%
37Other non-current liabilities
339.1
254.5
268.6
238.9
254.4
324.9
856.2
714.6
551.2
465.5
462.4
3.2%
38Total Non-Current Liabilities
1,907
1,733
1,585
1,422
1,519
2,105
3,957
3,873
3,817
2,509
2,395
2.3%
39Total Liabilities
2,308
2,114
1,983
1,887
2,023
2,683
4,879
4,735
4,748
3,531
3,540
4.4%
SHAREHOLDERS` EQUITY
40Common stock
2,152
2,085
2,048
1,999
1,982
2,003
4,743
4,486
4,543
4,420
-
8.3%
41Retained earnings / (deficit)
939.5
954.2
1,146
1,339
1,659
1,939
1,999
1,912
2,088
2,475
3,016
12.4%
42Accumulated other comprehensive income / (loss)
(68.2)
(240.7)
11.7
(159.8)
(235.5)
(61.2)
(209.8)
(320.7)
(328.7)
(292.3)
(113.1)
5.2%
43Noncontrolling interests
15.9
11.4
11.3
8
12.8
10.5
12.3
10
13.2
12.4
13.6
(1.5)%
44Total shareholders' equity
3,039
2,810
3,217
3,186
3,418
3,892
6,545
6,087
6,315
6,616
7,197
9%
45Total Liabilities and shareholders' Equity
5,346
4,925
5,200
5,073
5,441
6,575
11,424
10,822
11,064
10,147
10,737
7.2%
46Total Debt
1,568
1,478
1,316
1,183
1,284
1,803
3,280
3,248
3,383
2,203
2,087
2.9%
47Net Debt
1,319
1,195
1,115
962.6
964.9
1,583
2,932
3,040
3,176
2,031
1,648
2.3%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
110.8
110
290.9
304.1
407.7
397.4
243.9
107
378.2
614.6
785.1
21.6%
49Depreciation & amortization
143.7
188.1
178.3
225.9
197.2
219.2
553.1
552.9
565.2
476.2
486.5
13%
50Share-based compensation expense
16.1
18.8
22.2
24
23.8
26
57.7
39
56.5
57.4
61.7
14.4%
51Changes in working capital and other assets
(16)
107.2
(33.8)
(14.4)
(38.1)
47
(169.8)
58.1
(26.7)
(0.2)
8.1
-
52Net cash flows from operating activities
254.7
424.1
457.6
539.5
590.6
689.6
684.8
756.9
973.3
1,148
1,341
18.1%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(126.4)
(172.9)
(165.5)
(189.7)
(214.5)
(239.3)
(287.6)
(362)
(360.3)
(370.1)
(369)
11.3%
54Purchases of investments / marketable securities
-
(6.4)
-
(5)
-
(4.4)
-
-
(1.5)
(10.7)
(134)
40.3%
55Proceeds from maturities of marketable securities
-
-
-
-
-
-
-
-
3.9
-
-
-
56Other investing activities
(603.2)
75
(38.4)
(18.6)
(105.2)
(910.5)
(379)
(21.4)
(529.4)
769.6
(9.5)
(34)%
57Net cash flows from investing activities
(729.6)
(104.3)
(203.8)
(213.2)
(319.7)
(1,154)
(666.6)
(383.3)
(887.4)
388.8
(512.5)
(3.5)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(14.4)
(97.5)
(65.5)
(81.5)
(51.2)
(14.6)
(55.8)
(308.6)
(11.8)
(211.3)
(202.6)
30.3%
59Dividends paid, net
(65.2)
(93.2)
(102.9)
(112.5)
(123)
(133.8)
(163.2)
(183.5)
(200.6)
(219.9)
(241.8)
14%
60Debt issuance (repayments), net
626.9
(75.4)
(193.4)
(112.1)
(26.5)
484.5
372.2
(6.2)
121.5
(1,164)
(122)
-
61Other financing activities
13
(1)
5.7
11.3
37.6
9.6
(37.4)
(0.4)
5.7
23.3
(1.8)
-
62Net cash flows from financing activities
560.3
(267.1)
(356.2)
(294.8)
(163.1)
345.6
115.8
(498.7)
(85.2)
(1,572)
(568.2)
-
63Increase (decrease) in cash and cash equivalents
81.2
34.1
(81.4)
19.1
98.9
(99)
127.8
(140)
(1.3)
(35.3)
267.9
12.7%
64Cash and equivalents, ending balance
248.8
282.9
201.5
220.6
319.6
220.5
348.3
208.4
207
171.7
439.6
5.9%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
128.3
251.2
292.2
349.8
376
450.4
397.2
395
612.9
778
972.4
22.5%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
20262025202420232022202120202019

Steris (STE) financial statements and performance

Explore Steris (STE) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.